To elucidate the molecular mechanisms and immune regulatory networks involved in septic cardiomyopathy (SCM), emphasizing the significance of hypoxia-related immune remodeling.
Key Findings:
Septic myocardium showed activation of hypoxia-related signaling and immune landscape remodeling with increased macrophage infiltration, indicating a shift in immune dynamics.
NFIL3, TGM2, and SDC4 were identified as key hypoxia-associated hub genes with strong diagnostic performance, suggesting their potential as biomarkers.
Higher genetically predicted NFIL3 expression was significantly associated with increased sepsis risk, highlighting its role in disease susceptibility.
Single-cell analysis revealed predominant enrichment of Nfil3 in macrophages, confirming its critical role in SCM pathophysiology.
NFIL3 negatively regulates macrophage inflammatory responses, partly through inhibition of NF-κB signaling, suggesting a mechanism for its protective effects.
Interpretation:
The study highlights hypoxia-driven immune dysregulation as a central mechanism in septic cardiomyopathy, with NFIL3 identified as a critical immune regulator that may serve as a novel target for diagnosis and therapy, potentially improving patient outcomes.
Limitations:
The study primarily utilized mouse models, which may not fully replicate human SCM, potentially limiting the applicability of findings.
Further clinical validation is needed to confirm the findings in human populations, ensuring relevance to patient care.
Conclusion:
NFIL3 plays a significant role in the development of septic cardiac injury, suggesting potential molecular targets for early diagnosis and therapeutic intervention in sepsis-related myocardial damage, warranting further investigation.
